Systemic corticosteroids (SCS) are a highly effective treatment for acute exacerbations and
long-term symptom control in asthma. Long-term SCS use is highly prevalent across all …

Oral corticosteroids (OCS) have long been a mainstay of treatment for asthma exacerbations
and chronic severe asthma. However, it is increasingly recognized that both long-term and …

Aims To assess the cost-effectiveness of tezepelumab as add-on maintenance therapy
compared with standard of care (SoC) for the treatment of patients with severe asthma in …

Background Asthma hospitalizations declined rapidly in many parts of the world, including
Canada, in the 1990s and early 2000s. Objective To examine whether the declining trend of …

An algorithm to describe patterns of intermittent oral corticosteroid use in the UK (n=
476,167) found that one-third of patients receiving intermittent oral corticosteroids for asthma …

Background Cost-related nonadherence to medications can be a barrier to asthma
management. Objective To quantify the impact of public drug plan deductibles on adherence …

Background Systemic corticosteroid (SCS) use remains widespread among patients with
severe asthma, despite associated complications. Objective Evaluate the association …

Purpose Oral corticosteroids (OCS) are frequently used in asthma management but have an
important risk-profile. The aim of the study is to characterize and compare the …

Background: High costs of controller therapies may be a barrier to guideline-recommended
asthma treatment. We determined whether eliminating out-of-pocket (OOP) payments …

Oral corticosteroid are commonly prescribed medications known for their proven clinical
advantages in treating individuals with chronic inflammatory and autoimmune conditions …